1219 THREE-DAY, DOSE-RANGING STUDY OF THE HCV NS5A INHIBITOR GS-5885 - Concepedia

Concepedia

Publication | Closed Access

1219 THREE-DAY, DOSE-RANGING STUDY OF THE HCV NS5A INHIBITOR GS-5885

11

Citations

0

References

2011

Year

Eric Lawitz, Daniel Gruener, John M. Hill, T. Marbury, Steven F. Komjathy, Michael DeMicco, Abel Murillo, F. Jenkin, K. Kim, John T. Simpson,

Journal of Hepatology

Viral HepatitisPharmacologyAntiviral Drug DevelopmentHepatitisVirologyAntiviral TherapyPharmacotherapyAntiviral DrugDose-ranging StudyMedicineDrug Discovery

No additional data available for this publication yet. Check back later!